Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Clinical Outcome
7 results:

  • 1. Estrogen concentration and estrogen receptor-β expression in postmenopausal colon cancer considering patient/tumor background.
    Honma N; Arai T; Matsuda Y; Fukunaga Y; Akishima-Fukasawa Y; Yamamoto N; Kawachi H; Ishikawa Y; Takeuchi K; Mikami T
    J Cancer Res Clin Oncol; 2022 May; 148(5):1063-1071. PubMed ID: 35032217
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.
    Neves M; Azevedo R; Lima L; Oliveira MI; Peixoto A; Ferreira D; Soares J; Fernandes E; Gaiteiro C; Palmeira C; Cotton S; Mereiter S; Campos D; Afonso LP; Ribeiro R; Fraga A; Tavares A; Mansinho H; Monteiro E; Videira PA; Freitas PP; Reis CA; Santos LL; Dieguez L; Ferreira JA
    N Biotechnol; 2019 Mar; 49():77-87. PubMed ID: 30273682
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. MicroRNA let-7, T Cells, and Patient Survival in colorectal cancer.
    Dou R; Nishihara R; Cao Y; Hamada T; Mima K; Masuda A; Masugi Y; Shi Y; Gu M; Li W; da Silva A; Nosho K; Zhang X; Meyerhardt JA; Giovannucci EL; Chan AT; Fuchs CS; Qian ZR; Ogino S
    Cancer Immunol Res; 2016 Nov; 4(11):927-935. PubMed ID: 27737877
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment.
    Malara N; Trunzo V; Foresta U; Amodio N; De Vitis S; Roveda L; Fava M; Coluccio M; Macrì R; Di Vito A; Costa N; Mignogna C; Britti D; Palma E; Mollace V
    J Transl Med; 2016 May; 14(1):133. PubMed ID: 27176720
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer.
    Meshcheryakova A; Tamandl D; Bajna E; Stift J; Mittlboeck M; Svoboda M; Heiden D; Stremitzer S; Jensen-Jarolim E; Grünberger T; Bergmann M; Mechtcheriakova D
    PLoS One; 2014; 9(6):e99008. PubMed ID: 24905750
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab.
    Malka D; Boige V; Jacques N; Vimond N; Adenis A; Boucher E; Pierga JY; Conroy T; Chauffert B; François E; Guichard P; Galais MP; Cvitkovic F; Ducreux M; Farace F
    Ann Oncol; 2012 Apr; 23(4):919-27. PubMed ID: 21825101
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.
    Nosho K; Baba Y; Tanaka N; Shima K; Hayashi M; Meyerhardt JA; Giovannucci E; Dranoff G; Fuchs CS; Ogino S
    J Pathol; 2010 Dec; 222(4):350-66. PubMed ID: 20927778
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.